PFBT
ICPT

Parkside Financial Bank & Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-44
Closed -$7K – 1135
2015
Q3 		$7K Buy
+44
New +$9.68K ﹤0.01% 729

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's ICPT Position: Q4 2015 in Review

Parkside Financial Bank & Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2015, closing a stake of 44 shares — an estimated $7K sold.

Parkside Financial Bank & Trust first reported a position in ICPT in Q3 2015 and held it in 1 quarter. The position peaked at $7K in Q3 2015. 172 funds tracked by Wall St. Rank hold ICPT as of Q4 2015.

  • Parkside Financial Bank & Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 44 Intercept Pharmaceuticals, Inc. shares in Q4 2015, an estimated $7K.
  • Parkside Financial Bank & Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Intercept Pharmaceuticals, Inc. position peaked at $7K in Q3 2015.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2015.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2015, filed 2 Feb 2016.